Naveen Pemmaraju: Novel Tasquinimod-Based Combos in Advanced MPNs
Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive Director of Cancer Medicine, Director of BPDCN at the Department of Leukemia, and Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a post on LinkedIn about a paper he co-authored with colleagues published in Blood Advances:
“I am pleased to share our MPN group’s brand new collaborative original work just out in Blood Advances, led by Dr Bhalla, highlighting novel pre-clinical work in Tasquinimod-based combos in advanced MPN states.”
Title: Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms (MPN) in blastic phase
Authors: Warren Fiskus, Lucia Masarova, Christopher P Mill, Christine Birdwell, Kaberi Das, Hanxi Hou, John A Davis, Antrix Jain, Anna Malovannaya, Taghi Manshouri, Andrew Dunbar, Surbhi Sharma, Tapan M. Kadia, Courtney D. DiNardo, Prithviraj Bose, Naveen Pemmaraju, Sanam Loghavi, Xiaoping Su, Raajit K. Rampal, Marie Törngren, Kapil N Bhalla
You can read the Full Article on Blood Advances.
More posts featuring Naveen Pemmaraju.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023